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Two Dordt University 
professors are trying 
to raise community 
awareness about a 
genetic mutation in the 
phospholamban (PLN) 
gene, which can cause 
heart arrhythmias and 
possible cardiac death in 
people of Frisian descent.
Genetic studies have shown the 
mutation first appeared somewhere in 
the province of Friesland, Netherlands, 
around 700 years ago. 
“Since there are many Dutch 
descendants at Dordt, we believe there 
are potential carriers of the gene in 
our constituency. It would be good 
for them to know that they carry the 
mutation and take steps to treat potential 
complications,” says Professor of Nursing 
Dr. Deb Bomgaars. 
Symptoms of the disease include 
reduced stamina, shortness of breath, 
arrhythmias, heart rate surges, and full 
cardiac arrest. Some individuals show 
no symptoms, but that doesn’t make the 
condition any less serious. The mutation 
is dominant, meaning that it will be 
passed on to half of a person’s children 
on average—and their cases might not 
be asymptomatic.
Bomgaars first took interest in the 
genetic mutation when she found out 
that a close family member had tested 
positive for it. She remembers that, while 
in a meeting with Professor of Biology 
Dr. Tony Jelsma, he requested prayer 
for a family member hospitalized with a 
racing heart and mentioned that heart 
disease is prevalent in his family. She 
later pulled Jelsma aside and mentioned 
that he might want to investigate PLN. 
Jelsma and Bomgaars, along with 
Professors of Nursing Melanie Wynja 
and Deb Kleinwolterink, are working 
with Dr. Dean Jansen, a physician 
and administrator for the PLN Heart 
Foundation—and a PLN carrier 
himself—to help raise awareness for this 
dangerous mutation. 
Research into PLN provides a real-
life application to the content that he 
and Bomgaars teach, says Jelsma—
particularly in his human physiology and 
genetics classes.
“Despite knowing the molecular 
mechanism of this condition, the fact 
that it presents in a variety of ways and 
in different degrees of severity shows 
that there is still much we don’t know 
about our physiology,” says Jelsma. “Our 
bodies are complex, indeed! Moreover, 
we see how we can use our knowledge 
to save lives, whether it’s by developing 
treatments or cures, or whether it’s 
simply by raising awareness.”
Bomgaars says the research will impact 
her nursing students and beyond.
“This research helps me to collaborate 
with not only other departments on 
campus, but with the Dordt community,” 
she says. “By researching PLN, I can be of 
service to God’s creation. It is a way for 
me to help others be aware of potential 
heart problems that can be treated.”
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Professor of Nursing Deb Bomgaars became interested in the PLN gene, which originated 
in the Netherlands, after a family member tested positive for it.
Gene research is not new to Dr. Tony 
Jelsma, who is now helping raise 




















Moss: Investigating a Frisian Genetic Mutation
Published by Digital Collections @ Dordt,
